Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)‐producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland-Reference-Cited by-同舟云学术

Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)‐producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland

Published:2020-04-28 Issue:6 Volume:70 Page:440-446
ISSN:0266-8254
Container-title:Letters in Applied Microbiology
language:en
Short-container-title:Lett Appl Microbiol

Author:

Rastawicki W.¹^ORCID,Śmietańska K.¹,Rokosz‐Chudziak N.¹,Wołkowicz T.¹

Affiliation:

1. Department of Bacteriology and Biocontamination Control National Institute of Public Health – National Institute of Hygiene Warsaw Poland

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/lam.13295

Reference30 articles.

1. Non‐O157 Shiga Toxin–ProducingEscherichia coliInfections in the United States, 1983–2002

2. A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups

3. The serological relationship betweenYersinia enterocoliticaO9 andEscherichia coliO157 using sera from patients with yersiniosis and haemolytic uraemic syndrome

4. Antigenic cross-reactions between Escherichia coli O157, Vibrio cholerae O1 (Inaba) and group N salmonella

5. Commission Implementing Decision 2018/945(2018)On the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. OJ 6.7.2018 L 170/41.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Improve Surveillance Program for Shiga Toxin-Producing E. coli (STEC): Gap Analysis and Pilot Study;Pathogens;2024-06-17

2. Epidemiological Characteristics of Shiga Toxin-Producing Escherichia coli Responsible for Infections in the Polish Pediatric Population;Polish Journal of Microbiology;2024-05-10

3. Management of pediatric hemolytic uremic syndrome;The Turkish Journal of Pediatrics;2024-02-28

4. HUS and TTP: traversing the disease and the age spectrum;Seminars in Nephrology;2023-11

5. Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome;Toxins;2022-12-23